P91 Gemcitabine, epirubicin, and docetaxel (GED) asneoadjuvant therapy. Updated results from a multicenter phase II trial in locally advanced breast cancer
Titel:
P91 Gemcitabine, epirubicin, and docetaxel (GED) asneoadjuvant therapy. Updated results from a multicenter phase II trial in locally advanced breast cancer
Auteur:
Yardley, D. Whitworth, P. Greco, F. Dunbar, L. Burris, H. White, M. Melodie, M. Yost, K. Hainsworth, J.